Trial intelligence / Profile preview

MMF vs EC-MPS for GI Side Effects in Heart Transplant

NCT00468936Phase 3Unknown

Sponsor
McGill University Health Centre
Start
May 2007
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of mycophenolate sodium in heart transplant rejection, sponsored by McGill University Health Centre. Status: unknown.

02

Drugs

mycophenolate sodium
03

Conditions

heart transplant rejection

Beyond the preview

Go deeper on NCT00468936.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00468936.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call